Clinical outcomes and cost implications of routine early PCI after fibrinolysis: One-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study

Conclusions: At 1 year, there is no difference in the clinical composite outcome of death or reinfarction between r-PCI and s-PCI strategies. Greater cost with r-PCI, although statistically insignificant, is economically important.

Source: American Heart Journal - February 20, 2013 Category: Cardiology Authors: Akshay Bagai, Warren J. Cantor, Mary Tan, Wesley Tong, Andre Lamy, David Fitchett, Eric A. Cohen, Shamir R. Mehta, Bjug Borgundvaag, John Ducas, Michael Heffernan, Vladimír Džavík, Laurie Morrison, Brian Schwartz, Charles Lazzam, Anatoly Langer, Shaun Tags: Outcomes, Health Policy, and Managed Care Source Type: research